Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

H. G. Nuesslein, R. Alten, M. Galeazzi, H. -M. Lorenz, M. T. Nurmohamed, W. G. Bensen, G. R. Burmester, H. -H. Peter, P. Peichl, K. Pavelka, M. Chartier, C. Poncet, C. Rauch, M. Le Bars

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)489-499
JournalClinical and Experimental Rheumatology
Volume34
Issue number3
Publication statusPublished - 2016

Cite this

Nuesslein, H. G. ; Alten, R. ; Galeazzi, M. ; Lorenz, H. -M. ; Nurmohamed, M. T. ; Bensen, W. G. ; Burmester, G. R. ; Peter, H. -H. ; Peichl, P. ; Pavelka, K. ; Chartier, M. ; Poncet, C. ; Rauch, C. ; Le Bars, M. / Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. In: Clinical and Experimental Rheumatology. 2016 ; Vol. 34, No. 3. pp. 489-499.
@article{f11bbb6cade548bbbff029945818d54e,
title = "Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study",
keywords = "abatacept, biological therapy, cohort studies, cyclic citrullinated peptide, rheumatoid arthritis, rheumatoid factor",
author = "Nuesslein, {H. G.} and R. Alten and M. Galeazzi and Lorenz, {H. -M.} and Nurmohamed, {M. T.} and Bensen, {W. G.} and Burmester, {G. R.} and Peter, {H. -H.} and P. Peichl and K. Pavelka and M. Chartier and C. Poncet and C. Rauch and {Le Bars}, M.",
year = "2016",
language = "English",
volume = "34",
pages = "489--499",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "3",

}

Nuesslein, HG, Alten, R, Galeazzi, M, Lorenz, H-M, Nurmohamed, MT, Bensen, WG, Burmester, GR, Peter, H-H, Peichl, P, Pavelka, K, Chartier, M, Poncet, C, Rauch, C & Le Bars, M 2016, 'Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study' Clinical and Experimental Rheumatology, vol. 34, no. 3, pp. 489-499.

Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study. / Nuesslein, H. G.; Alten, R.; Galeazzi, M.; Lorenz, H. -M.; Nurmohamed, M. T.; Bensen, W. G.; Burmester, G. R.; Peter, H. -H.; Peichl, P.; Pavelka, K.; Chartier, M.; Poncet, C.; Rauch, C.; Le Bars, M.

In: Clinical and Experimental Rheumatology, Vol. 34, No. 3, 2016, p. 489-499.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Efficacy and prognostic factors of treatment retention with intravenous abatacept for rheumatoid arthritis: 24-month results from an international, prospective, real-world study

AU - Nuesslein, H. G.

AU - Alten, R.

AU - Galeazzi, M.

AU - Lorenz, H. -M.

AU - Nurmohamed, M. T.

AU - Bensen, W. G.

AU - Burmester, G. R.

AU - Peter, H. -H.

AU - Peichl, P.

AU - Pavelka, K.

AU - Chartier, M.

AU - Poncet, C.

AU - Rauch, C.

AU - Le Bars, M.

PY - 2016

Y1 - 2016

KW - abatacept

KW - biological therapy

KW - cohort studies

KW - cyclic citrullinated peptide

KW - rheumatoid arthritis

KW - rheumatoid factor

M3 - Article

VL - 34

SP - 489

EP - 499

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 3

ER -